569 related articles for article (PubMed ID: 30338716)
1. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
Panoutsopoulou K; Avgeris M; Scorilas A
Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
3. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a Systematic Overview.
Thankachan S; Bhardwaj BK; Venkatesh T; Suresh PS
Reprod Sci; 2021 Sep; 28(9):2436-2447. PubMed ID: 33569749
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers.
Klinge CM
Endocr Relat Cancer; 2018 Apr; 25(4):R259-R282. PubMed ID: 29440232
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
12. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of non-coding RNAs in ovarian cancer.
Sun N; Liu S; Chen A
J Obstet Gynaecol; 2022 Nov; 42(8):3416-3423. PubMed ID: 36476021
[TBL] [Abstract][Full Text] [Related]
14. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of non-coding RNA in oral cancer.
Momen-Heravi F; Bala S
Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
[TBL] [Abstract][Full Text] [Related]
16. LncRBase V.2: an updated resource for multispecies lncRNAs and ClinicLSNP hosting genetic variants in lncRNAs for cancer patients.
Das T; Deb A; Parida S; Mondal S; Khatua S; Ghosh Z
RNA Biol; 2021 Aug; 18(8):1136-1151. PubMed ID: 33112702
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
20. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
